Expert Opinion on Biological Therapy, Volume 21, Issue 5 (2021)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Biological Therapy, Volume 21, Issue 5 (2021)

See all volumes and issues
Vol 24, 2024 Vol 23, 2023 Vol 22, 2022 Volume 21, 2021 Vol 20, 2020 Vol 19, 2019 Vol 18, 2018 Vol 17, 2017 Vol 16, 2016 Vol 15, 2015 Vol 14, 2014 Vol 13, 2013 Vol 12, 2012 Vol 11, 2011 Vol 10, 2010 Vol 9, 2009 Vol 8, 2008 Vol 7, 2007 Vol 6, 2006 Vol 5, 2005 Vol 4, 2004 Vol 3, 2003 Vol 2, 2002 Vol 1, 2001
Download citations Download PDFs Download issue

Editorial

Editorial
Regulatory challenges and considerations for the clinical application of CAR T cell therapy
Christina A Bachmeier, Tony J Kurian & Marco L Davila
Pages: 549-552
Published online: 24 Feb 2021
First Page PreviewforRegulatory challenges and considerations for the clinical application of CAR T cell therapy | Full Text | References | PDF (161.9 KB) | EPUB
  • 2354 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Drug Evaluation

Article
Brolucizumab: a novel anti-VEGF humanized single-chain antibody fragment for treating w-AMD
Lorenzo Ferro Desideri, Carlo Enrico Traverso & Massimo Nicolò
Pages: 553-561
Published online: 24 Apr 2021
AbstractforBrolucizumab: a novel anti-VEGF humanized single-chain antibody fragment for treating w-AMD | Full Text | References | PDF (947.7 KB) | EPUB
  • 461 Views
  • 2 CrossRef citations
  • 0Altmetric
Article
Belimumab: a step forward in the treatment of systemic lupus erythematosus
Roberto Depascale, Mariele Gatto, Margherita Zen, Francesca Saccon, Maddalena Larosa, Elisabetta Zanatta, Sara Bindoli, Andrea Doria & Luca Iaccarino
Pages: 563-573
Published online: 12 Mar 2021
AbstractforBelimumab: a step forward in the treatment of systemic lupus erythematosus | Full Text | References | PDF (399.1 KB) | EPUB
  • 488 Views
  • 9 CrossRef citations
  • 0Altmetric
Article
Dupilumab for the treatment of chronic rhinosinusitis with nasal polyposis
Wytske Fokkens, Rik Van Der Lans & Sietze Reitsma
Pages: 575-585
Published online: 01 Apr 2021
AbstractforDupilumab for the treatment of chronic rhinosinusitis with nasal polyposis | Full Text | References | PDF (3.4 MB) | EPUB
  • 6238 Views
  • 12 CrossRef citations
  • 0Altmetric
Open Access

Review

B7-H3 targeted antibody-based immunotherapy of malignant diseases
Theodoros Michelakos, Filippos Kontos, Omar Barakat, Luke Maggs, Joseph H. Schwab, Cristina R. Ferrone & Soldano Ferrone
Pages: 587-602
Published online: 21 Dec 2020
AbstractforB7-H3 targeted antibody-based immunotherapy of malignant diseases | Full Text | References | PDF (3.1 MB) | EPUB
  • 503 Views
  • 11 CrossRef citations
  • 0Altmetric
RNA therapeutics for retinal diseases
Michael C Gemayel, Ashay D. Bhatwadekar & Thomas Ciulla
Pages: 603-613
Published online: 16 Dec 2020
AbstractforRNA therapeutics for retinal diseases | Full Text | References | PDF (3 MB) | EPUB
  • 629 Views
  • 10 CrossRef citations
  • 0Altmetric
A comprehensive review on sarilumab in COVID-19
Sajad Khiali, Afra Rezagholizadeh & Taher Entezari-Maleki
Pages: 615-626
Published online: 25 Nov 2020
AbstractforA comprehensive review on sarilumab in COVID-19 | Full Text | References | PDF (1.9 MB) | EPUB
  • 4909 Views
  • 29 CrossRef citations
  • 0Altmetric
Lymphodepletion strategies to potentiate adoptive T-cell immunotherapy – what are we doing; where are we going?
Natasha Bechman & John Maher
Pages: 627-637
Published online: 28 Dec 2020
AbstractforLymphodepletion strategies to potentiate adoptive T-cell immunotherapy – what are we doing; where are we going? | Full Text | References | PDF (368.2 KB) | EPUB
  • 1055 Views
  • 20 CrossRef citations
  • 0Altmetric
The use of anti-TNF-alpha therapies for patients with systemic lupus erythematosus. Where are we now?
Ana Lorenzo-Vizcaya & David A. Isenberg
Pages: 639-647
Published online: 06 Jan 2021
AbstractforThe use of anti-TNF-alpha therapies for patients with systemic lupus erythematosus. Where are we now? | Full Text | References | PDF (376.8 KB) | EPUB
  • 478 Views
  • 7 CrossRef citations
  • 0Altmetric
Cell therapy for cytomegalovirus infection
Lorna Neill & Karl Peggs
Pages: 649-659
Published online: 21 Dec 2020
AbstractforCell therapy for cytomegalovirus infection | Full Text | References | PDF (712.9 KB) | EPUB
  • 350 Views
  • 5 CrossRef citations
  • 0Altmetric
Tailoring biologic therapy for real-world rheumatoid arthritis patients
Ciro Romano, Sergio Esposito, Roberta Ferrara & Giovanna Cuomo
Pages: 661-674
Published online: 15 Nov 2020
AbstractforTailoring biologic therapy for real-world rheumatoid arthritis patients | Full Text | References | PDF (1.5 MB) | EPUB
  • 174 Views
  • 4 CrossRef citations
  • 0Altmetric

Original Research

Article
A two-arm, randomized, controlled, multi-centric, open-label phase-2 study to evaluate the efficacy and safety of Itolizumab in moderate to severe ARDS patients due to COVID-19
Suresh Kumar, Rosemarie De Souza, Milind Nadkar, Randeep Guleria, Anjan Trikha, Shashank R. Joshi, Subramanian Loganathan, Sivakumar Vaidyanathan, Ashwani Marwah & Sandeep N. Athalye
Pages: 675-686
Published online: 09 Apr 2021
AbstractforA two-arm, randomized, controlled, multi-centric, open-label phase-2 study to evaluate the efficacy and safety of Itolizumab in moderate to severe ARDS patients due to COVID-19 | Full Text | References | PDF (2.1 MB) | EPUB
  • 3311 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access
Article
The effect of platelet-rich plasma-fibrin glue dressing in combination with oral vitamin E and C for treatment of non-healing diabetic foot ulcers: a randomized, double-blind, parallel-group, clinical trial
Amir Yarahmadi, Mohammad-Hadi Saeed Modaghegh, Zohreh Mostafavi-Pour, Negar Azarpira, Alireza Mousavian, Shokoufeh Bonakdaran, Lida Jarahi, Alireza Samadi, Meghdad Peimani & Daryoush Hamidi Alamdari
Pages: 687-696
Published online: 13 Apr 2021
AbstractforThe effect of platelet-rich plasma-fibrin glue dressing in combination with oral vitamin E and C for treatment of non-healing diabetic foot ulcers: a randomized, double-blind, parallel-group, clinical trial | Full Text | References | PDF (1.7 MB) | EPUB
  • 339 Views
  • 0 CrossRef citations
  • 0Altmetric

Correction

Correction
Correction
Page: i
Published online: 30 Sep 2020
CitationforCorrection | Full Text | PDF (133.5 KB) | EPUB
  • 472 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Explore articles

Explore the most recently published articles

Understanding patient variability to biologic treatments in inflammatory bowel disease
Ahmad Z. Al Meslamani
Editorial | Published online: 26 May 2024
Free Access
Next-generation CD40 agonists for cancer immunotherapy
Hampus Andersson et al.
Review Article | Published online: 23 May 2024
Open Access
Non-TNF biologics and their biosimilars in rheumatoid arthritis
Tsz Ching Mok et al.
Review Article | Published online: 22 May 2024
Could siRNA therapeutics change the way we treat dyslipidemia?
Peter E. Penson et al.
Editorial | Published online: 22 May 2024
Free Access
View all latest articles